Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1998
09/11/1998WO1998039481A1 Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds
09/11/1998WO1998039477A2 DIAGNOSING ASTHMA PATIENTS PREDISPOSED TO ADVERSE β-AGONIST REACTIONS
09/11/1998WO1998039476A1 Method of identifying gene encoding type ii membrane protein
09/11/1998WO1998039474A1 Non-invasive prenatal diagnosis
09/11/1998WO1998039472A2 Method for detecting mutated allels
09/11/1998WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
09/11/1998WO1998039466A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
09/11/1998WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
09/11/1998WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
09/11/1998WO1998039463A2 Lentivirus based vector and vector system
09/11/1998WO1998039462A1 Method of hybrid seed production using conditional female sterility
09/11/1998WO1998039461A1 Methods of commercial production and extraction of protein from seed
09/11/1998WO1998039460A1 Nucleic acid molecules from artichoke ($i(cynara scolymus)) encoding enzymes having fructosyl polymerase activity
09/11/1998WO1998039459A1 PROMOTERS OF THE GENES GLUTAMATE DESHYDROGENASE, β-N-ACETYLHEXOSAMINIDASE AND $b(g)-ACTINE, AND THEIR USE IN SYSTEMS OF EXPRESSION, SECRETION AND ANTI-SENS IN FILAMENTARY FUNGI
09/11/1998WO1998039456A1 Factor x variant
09/11/1998WO1998039455A1 NOVEL GENE, GROUP OF GENES, AND NOVEL β-GLUCLOSIDASE
09/11/1998WO1998039454A1 Method for modulating the biomass of plants
09/11/1998WO1998039453A1 Methods for the biosynthesis of polyesters
09/11/1998WO1998039452A1 Dna fragments containing biotin biosynthetase gene and use of the same
09/11/1998WO1998039451A1 Feline immunodeficiency virus clone jsy3
09/11/1998WO1998039450A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS
09/11/1998WO1998039449A1 COMPOSITIONS AND USE OF M-CSF-alpha
09/11/1998WO1998039448A9 186 human secreted proteins
09/11/1998WO1998039448A2 186 human secreted proteins
09/11/1998WO1998039447A1 Prostate cancer-specific marker
09/11/1998WO1998039446A2 70 human secreted proteins
09/11/1998WO1998039445A1 Human tubby homolog
09/11/1998WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2)
09/11/1998WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO
09/11/1998WO1998039442A1 Human mitochondrial membrane protein
09/11/1998WO1998039441A1 Human chemokine receptor-like chemokine
09/11/1998WO1998039440A2 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
09/11/1998WO1998039439A1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
09/11/1998WO1998039437A1 Novel apoptosis-related dnas
09/11/1998WO1998039436A2 Fibroblast growth factor mutein compositions and methods of use therefor
09/11/1998WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors
09/11/1998WO1998039434A1 Methods and reagents for modulating apoptosis
09/11/1998WO1998039433A1 Complement receptor type 1 (cr1)-like sequences
09/11/1998WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family
09/11/1998WO1998039431A1 Sr-bi regulatory sequences and therapeutic methods of use
09/11/1998WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998WO1998039429A2 Compositions for treatment of disorders involving programmed cell death
09/11/1998WO1998039428A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
09/11/1998WO1998039427A2 Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters
09/11/1998WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998WO1998039425A2 Vectors and methods for expression of mutant proteins
09/11/1998WO1998039424A1 Dna encoding pneumocystis carinii protease
09/11/1998WO1998039422A1 Methods and compositions for controlling cell death and disease resistance in plants
09/11/1998WO1998039420A1 Filtration method for separating viruses
09/11/1998WO1998039419A1 Plants having resistance to multiple herbicides and their use
09/11/1998WO1998039418A1 New applications of gene therapy technology
09/11/1998WO1998039417A2 Human liver cell line
09/11/1998WO1998039416A1 Method of cloning animals
09/11/1998WO1998039413A1 Models for haematopoiesis
09/11/1998WO1998039412A1 Immunosuppression
09/11/1998WO1998039411A1 Adenovirus e1-complementing cell lines
09/11/1998WO1998039410A1 IλB $i(KINASES)
09/11/1998WO1998039363A2 Immunotoxins and methods of inducing immune tolerance
09/11/1998WO1998039361A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
09/11/1998WO1998039359A1 Dimeric cationic lipids on dicystine basis
09/11/1998WO1998039358A1 Oligomeric cationic lipids
09/11/1998WO1998039352A1 Novel bicyclonucleoside and oligonucleotide analogues
09/11/1998WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/11/1998WO1998039030A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998WO1998039022A1 Methods of using exendin and glp-1, and agonists and antagonists thereof, to affect the central nervous system
09/11/1998WO1998038861A1 Antisense compounds which prevent cell death and uses thereof
09/11/1998WO1998038846A2 Genetic compositions and methods
09/11/1998WO1998031817A3 Human lysosomal sialidase and therapeutic uses thereof
09/11/1998WO1998031795A3 Novel human metallothionein
09/11/1998WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998WO1998030702A3 Polynucleotides encoding choline monooxygenase and plants transformed therewith
09/11/1998WO1998030692A3 Human endosulfine gene
09/11/1998WO1998030687A3 Protein containing an srcr domain
09/11/1998WO1998030686A3 Method of purifying dna in a cross-flow centrifuge
09/11/1998WO1998030584A3 Secreted proteins and polynucleotides encoding them
09/11/1998WO1998029536A3 Reversibly inactive synthetic beta-galactosidase
09/11/1998WO1998029438A3 Cortistatin polypeptides
09/11/1998WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
09/11/1998WO1998025956A3 Human GTP-binding proteins
09/11/1998WO1998024912A3 Recombinant plague vaccine
09/11/1998WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins
09/11/1998WO1998013488A3 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
09/11/1998WO1998000565A3 NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(MYCOPLASMA PNEUMONIAE)
09/11/1998CA2375804A1 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same
09/11/1998CA2286394A1 Diagnosing asthma patients predisposed to adverse .beta.-agonist reactions
09/11/1998CA2285677A1 Human liver cell line
09/11/1998CA2284131A1 70 human secreted proteins
09/11/1998CA2284078A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
09/11/1998CA2283497A1 Vectors and methods for expression of mutant proteins
09/11/1998CA2283460A1 Plants having resistance to multiple herbicides and their use
09/11/1998CA2283394A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998CA2283379A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication
09/11/1998CA2283299A1 186 human secreted proteins
09/11/1998CA2283253A1 Adenovirus e1-complementing cell lines
09/11/1998CA2283241A1 Filtration method for separating viruses
09/11/1998CA2283188A1 Method for detecting mutated alleles
09/11/1998CA2283161A1 Immunosuppression
09/11/1998CA2283076A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998CA2283068A1 Methods and compositions for the treatment of injury to the central nervous system
09/11/1998CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto
1 ... 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 ... 4023